Surgical oncology during the post-COVID-19 era: What is next? |
| |
| Authors: | Georgios D Lianos MD PhD Maximos Frountzas MD MPA PhD Dimitrios Schizas MD PhD Evangelos G Baltagiannis MD George A Alexiou MD PhD Christina Bali MD PhD Georgios K Glantzounis MD PhD Michail Mitsis MD PhD Konstantinos Vlachos MD PhD |
| |
| Affiliation: | 1. Department of Surgery, School of Health Sciences, University Hospital of Ioannina and Faculty of Medicine, University of Ioannina, Ioannina, Greece;2. First Propaedeutic Department of Surgery, National and Kapodistrian University of Athens, Hippocration General Hospital, Athens, Greece;3. First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece;4. Department of Neurosurgery, University Hospital of Ioannina, Ioannina, Greece |
| |
| Abstract: | During first outburst of COVID-19, several strategies had been applied for surgical oncology patients to minimize COVID-19 transmission. COVID-19 infection seemed to compromise survival and major complication rates of surgical oncology patients. However, survival, tumor progression and recurrence rates of surgical oncology patients were associated to the consequences of COVID-19 pandemic on their management. In addition, the severity of COVID-19 infections has been downgraded. Therefore, management of surgical oncology patients should be reconsidered. |
| |
| Keywords: | cancer COVID-19 multidisciplinary surgical treatment |
|
|
